Healthcare products maker Covidien plc (
) on Tuesday saw its price target and earnings estimates raised by
analysts at Goldman Sachs.
The firm said it now expects COV shares to reach $60, implying a
15% upside to the stock's Monday closing price of $52.
Goldman Sachs also maintained its its "Buy" rating and raised
its earnings estimates for the company, citing further share
Covidien shares were unchanged in premarket trading Tuesday.
The Bottom Line
Shares of Covidien (
) have a 1.54% dividend yield, based on last night's closing stock
price of $52.00. The stock has technical support in the $45-$50
price area. The stock is trading in the all-time high range of
$55-$57 a share.
Covidien plc (
) is not recommended at this time, holding a Dividend.com DARS™
Rating of 3.3 out of 5 stars.
Be sure to visit our complete recommended list of the
Best Dividend Stocks
, as well as a detailed explanation of
our ratings system here
Created by Dividend.com